EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

First Treatment for Breast Cancer with certain Inherited Gene Mutation

Naseer Sulaiman

Scientific Journal of Genetics and Gene Therapy · 2018

DOI: 10.17352/sjggt.000013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Journal of Genetics and Gene Therapy, 2018. Verfasst von Naseer Sulaiman. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.

Zitieren

APA

Sulaiman, N. (2018). First Treatment for Breast Cancer with certain Inherited Gene Mutation. Scientific Journal of Genetics and Gene Therapy. https://doi.org/10.17352/sjggt.000013

Vancouver

Sulaiman N. First Treatment for Breast Cancer with certain Inherited Gene Mutation. Scientific Journal of Genetics and Gene Therapy. 2018. doi:10.17352/sjggt.000013

BibTeX
@article{Sulaiman2018,
  author = {Sulaiman, Naseer},
  title = {First Treatment for Breast Cancer with certain Inherited Gene Mutation},
  journal = {Scientific Journal of Genetics and Gene Therapy},
  year = {2018},
  doi = {10.17352/sjggt.000013}
}
Kostenlos starten →